A Phase II, Randomized, Safety and Immunogenicity Trial of a Re-Derived, Live-Attenuated Dengue Virus Vaccine in Healthy Children and Adults Living in Puerto Rico
Kristen M. Bauer, Bruce L. Innis(Universidad de Los Andes, Chile), Jorge Bertrán‐Pasarell(Ponce Health Sciences University), Ana I. Quintero del Rio, Ines O. Esquilin(Ponce Health Sciences University), Alberto S. Cornier(Ponce Health Sciences University), Stefan Fernandez(Armed Forces Research Institute of Medical Science), Stephen J. Thomas(Global Viral), Jean‐François Toussaint(Université Paris Cité), Kenneth H. Eckels(Walter Reed Army Institute of Research), Javier O. Morales Ramirez(Ponce Health Sciences University), Elodie Tournay(Walter Reed Army Institute of Research), Arthur Lyons(Ponce Health Sciences University), Clemente Díaz(University of Puerto Rico System), Simón Carlo(Ponce Health Sciences University), Wellington Sun, Rafael De La Barrera(Walter Reed Army Institute of Research)
Cited by 35
Related Papers
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
|New England Journal of Medicine|2020|15.7k
Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents
|New England Journal of Medicine|2021|937
Combination Antiretroviral Strategies for the Treatment of Pregnant HIV-1–Infected Women and Prevention of Perinatal HIV-1 Transmission
|JAIDS Journal of Acquired Immune Deficiency Syndromes|2002|896
Maternal Viral Load, Zidovudine Treatment, and the Risk of Transmission of Human Immunodeficiency Virus Type 1 from Mother to Infant
|New England Journal of Medicine|1996|817
Combination Antiretroviral Strategies for the Treatment of Pregnant HIV-1–Infected Women and Prevention of Perinatal HIV-1 Transmission
|JAIDS Journal of Acquired Immune Deficiency Syndromes|2002|697